Shwan Jalal, MD
Cardiovascular Disease · Gulfport, MSNPI 1558673384
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.5%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 20.0%. Reporting peaked in 2019 at $2,911 and has fallen 62.2% since, to $1,100 in 2025.
Across 318 payments — averaging $32.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$2K
- Medtronic$2K
- Abiomed$952
- E.r. Squibb & Sons, L.L.C.$481
- Johnson & Johnson$420
- plus $3K from 31 others
What the payments were for
- Travel & lodging$4,38242%
- Food & beverage$5,86057%
- Education$460%
- Gifts$751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $2,068 |
| Abbott | 35 | $1,857 |
| Medtronic(2 entities) | 22 | $1,710 |
| Abiomed | 35 | $952 |
| E.r. Squibb & Sons, L.L.C. | 29 | $481 |
| Johnson & Johnson | 30 | $420 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 25 | $348 |
| Novartis | 20 | $327 |
| Pfizer | 16 | $257 |
| Merck | 12 | $244 |
| Philips North America LLC | 10 | $193 |
| Boehringer Ingelheim | 11 | $188 |
| Amgen | 11 | $159 |
| Biotronik Inc. | 6 | $112 |
| Regeneron Healthcare Solutions, Inc. | 7 | $111 |
| Chiesi USA, Inc. | 3 | $105 |
| AstraZeneca | 8 | $104 |
| Sanofi-aventis U.S. LLC | 5 | $97 |
| Novo Nordisk | 3 | $83 |
| Angiodynamics, Inc. | 1 | $82 |
| W. L. Gore & Associates, Inc. | 1 | $60 |
| Baxter Healthcare | 1 | $45 |
| Kowa Pharmaceuticals America, Inc. | 3 | $43 |
| Bayer | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Cardiovascular Systems Inc. | 2 | $28 |
| Cvrx, Inc. | 1 | $27 |
| Atricure, Inc. | 1 | $27 |
| Penumbra, Inc. | 1 | $22 |
| Celonova Biosciences, Inc. | 1 | $19 |
| Heartflow, Inc. | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| EKOS Corporation | 1 | $14 |
| Terumo Medical Corporation | 1 | $14 |
| Impulse Dynamics (USA) Inc. | 1 | $13 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,363 in reported general payments places this provider in the 75th percentile of 144 cardiovascular disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Gulfport
- Umair MalikGulfport$21K
- Wakkas TayaraGulfport$10K
- Bassam BaroudiGulfport$7K
- James HardwickGulfport$6K
- Dharmesh PatelSouthaven$1.5M
- Barry BertoletTupelo$469K
- Donny StokesJackson$207K
- Mahmoud ZayedPascagoula$103K
- James BenslerJackson$64K
- Michael HallJackson$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.